Research Paper Volume 11, Issue 23 pp 11490—11503

Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib

Figure 1. (A) The overall DFS curve of high-risk (T3/4 or N1) ccRCC patients treated with adjuvant sunitinib or placebo. (B) Conditional DFS (CDFS) curves according to the number of years after randomization. Traditional Kaplan-Meier estimates of DFS (the starting point of the X axis = 0) overlaid by conditional DFS estimates at 1yr (the starting point of the X axis = 1), 2yr (the starting point of the X axis = 2), 3yr (the starting point of the X axis = 3) and so on are shown from the time of randomization.